WallStreetZenWallStreetZen

NASDAQ: SNOA
Sonoma Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their SNOA stock forecasts and price targets.

Forecast return on equity

Is SNOA forecast to generate an efficient return?

Company
3.6%
Industry
37.23%
Market
153.69%
SNOA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SNOA forecast to generate an efficient return on assets?

Company
0.91%
Industry
17.49%
SNOA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SNOA earnings per share forecast

What is SNOA's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.46
Avg 2 year Forecast
$0.07

SNOA revenue forecast

What is SNOA's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$21.9M+23.55%
Avg 2 year Forecast
$27.5M+55.14%
SNOA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SNOA revenue growth forecast

How is SNOA forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
24.56%
Industry
8.95%
Market
16.15%
SNOA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SNOA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SNOA vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
SNOA$1.20N/AN/A
BGM$0.30N/AN/A
AKAN$57.09N/AN/A
UPC$3.21N/AN/A
IMCC$0.29N/AN/A
View Top Pharmaceutical Stocks

Sonoma Pharmaceuticals Stock Forecast FAQ

What is SNOA's earnings growth forecast for 2027-2028?

(NASDAQ: SNOA) Sonoma Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 20.17%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 69.61%.

Sonoma Pharmaceuticals's earnings in 2026 is -$3,370,000.On average, 3 Wall Street analysts forecast SNOA's earnings for 2027 to be -$799,716, with the lowest SNOA earnings forecast at -$768,219, and the highest SNOA earnings forecast at -$823,253.

In 2028, SNOA is forecast to generate $123,566 in earnings, with the lowest earnings forecast at $118,720 and the highest earnings forecast at $127,200.

If you're new to stock investing, here's how to buy Sonoma Pharmaceuticals stock.

What is SNOA's revenue growth forecast for 2027-2028?

(NASDAQ: SNOA) Sonoma Pharmaceuticals's forecast annual revenue growth rate of 24.56% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 8.95%, and it is also forecast to beat the US market's average forecast revenue growth rate of 16.15%.

Sonoma Pharmaceuticals's revenue in 2026 is $17,722,000.On average, 3 Wall Street analysts forecast SNOA's revenue for 2027 to be $37,891,772, with the lowest SNOA revenue forecast at $36,406,906, and the highest SNOA revenue forecast at $39,006,286.

In 2028, SNOA is forecast to generate $47,581,474 in revenue, with the lowest revenue forecast at $45,715,873 and the highest revenue forecast at $48,979,809.

What is SNOA's forecast return on assets (ROA) for 2027-2028?

(NASDAQ: SNOA) forecast ROA is 0.91%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 17.49%.

What is SNOA's Earnings Per Share (EPS) forecast for 2027-2028?

(NASDAQ: SNOA) Sonoma Pharmaceuticals's current Earnings Per Share (EPS) is -$1.95. On average, analysts forecast that SNOA's EPS will be -$0.46 for 2027, with the lowest EPS forecast at -$0.44, and the highest EPS forecast at -$0.48. In 2028, SNOA's EPS is forecast to hit $0.07 (min: $0.07, max: $0.07).

What is SNOA's forecast return on equity (ROE) for 2027-2028?

(NASDAQ: SNOA) forecast ROE is 3.6%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.